2796 Pharmarise Holdings
- 524
- 00.00%
Pharmarise Holdings News
As soon as the news of Japan easing tourist visas for people from China was released, local retail travel stocks surged immediately.
① The Japanese Foreign Minister, Toshimitsu Motegi, announced the relaxation of visa requirements for Chinese tourists to Japan, expected to be implemented in spring 2025. ② After the announcement, retail and tourism-related stocks in Japan rose, with J. Front Retailing Co. soaring by 8.38%, while Isetan Mitsukoshi Holdings and Takashimaya increased by 6.98% and 3.69%, respectively.
China and Japan will introduce policies to facilitate tourism, and Japanese retail and tourism stocks have responded with an increase.
Retail and tourism-related stocks in Japan rose after the Chinese government and the Japanese government agreed to introduce more facilitation measures to promote mutual visits of tourists between the two countries.
Pharmarise Holdings: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending May 31, 2020 [Japanese GAAP] (consolidated)
Pharmarise Holdings: Notice regarding differences between consolidated earnings forecasts and actual values for the 2nd quarter (interim period) of the fiscal year ending May 31, 2020, and revisions to the full-year consolidated earnings fo...
Asahi, Ichibanya, Zojirushi, Shimamura (23rd)
The above Calendar is only a schedule and may be subject to change depending on the company's circumstances. --------------------------------------- December 23 (Mon) <3160> Daiko <3333> Asahi <7630> Ichibanya <7965> Zojirushi Mahobin <8227> Shimamura --------------------------------------- December 24 (
Driven by the weak yen, the consumer spending of tourists visiting Japan in the first 9 months has reached a new high.
①Driven by the weakness of the Japanese yen, Japan's tourism industry is extremely hot in 2024; ②Data shows that as of September, international tourists spent 5.86 trillion yen in Japan (equivalent to 39.27 billion US dollars); ③This exceeded the consumption record of 5.3 trillion yen set for the full year of 2023.
Pharmarise Swings to Loss in Three Months Ended August 31
Pharmarise Holdings Faces Profitability Challenges
September 26th [Today's Investment Strategy]
[FISCO Selected Stock] [Material Stock] Asentec <3565> 581 yen (9/25) Engaged in product development related to virtual desktops. Announced a capital and business alliance with US company CSG, which provides enterprise software solutions. Asentec will allocate 0.7 million shares of common stock to CSG through a third-party allotment (holding ratio after third-party allotment 5.01%). In order to provide higher quality virtual desktop system construction, engineering resources.
Focus on PS and J Oil [Individual stock movements today]
In the U.S. stock market on the 25th, the Dow Jones Industrial Average closed at 41,914.75, down 293.47 points, while the Nasdaq Composite Index rose 7.69 points to 18,082.21. In the Chicago Nikkei 225 futures market, the Osaka day-session price was 320 yen higher at 37,980 yen. The exchange rate was 1 dollar = 144.70-80 yen. In today's Tokyo market, TSI HD <3608> raised its forecast for the first half of the fiscal year ending in February 2025, PS <1871> revised its profit forecast for the fiscal year ending in September 2024, and revised upwards its profit forecast for the first half of the fiscal year ending in March 2025.
Japan oracle corp, 1Q operating profit increased by 20.2% to 22.1 billion yen
Japan's Oracle Corp <4716> announced its performance for the first quarter of the fiscal year ending in May 2025, with revenue increasing by 11.4% year-on-year to 63.915 billion yen, and operating profit increasing by 20.2% to 22.194 billion yen. It achieved record highs in revenue, operating profit, ordinary profit, and net profit for the first quarter. Operating profit exceeded the consensus (approximately 19.6 billion yen). [Positive evaluation] <1871> PS Construction Revised | <4716> Japan Oracle Quarterly <68
Pharmarise Holdings: Summary of financial results for the 1st quarter of the fiscal year ending May 31, 2019 [Japanese GAAP] (consolidated)
Pharmarise 1Q Loss Y131.00M Vs Net Y123.00M
Asahi, Sugi HD (24th)
※The above calendar is a tentative schedule and may be subject to change due to company's convenience. --------------------------------------- September 24th (Tuesday) <3333> Asahi <7649> Sugi HD --------------------------------------- September 25th (Wednesday) <2796> PharmaRise <3160> Daikoh <4465> Niitaka
Pharmarise Holdings: Confirmatory letter.
Pharmarise Holdings: Financial Report - 38th Term (2023/06/01 - 2024/05/31)
Pharmarise Holdings: Extraordinary Report
Pharmarise Holdings: Announcement regarding the dividends of surplus funds.
Pharmarise Holdings Faces Profit Decline, Eyes Recovery
Buy demand next week for Maesawa Chemical Industry and others.
[Buy demand for next week (table)] Code; Stock; Stock price impact; Buy demand; Credit multiplier; Closing price; Previous day comparison <9046>: Kobe Electric Railway; 390%; 35,900; 0.06; 2772; -3 <2796>: Farmalize; 345%; 7,600; 7.09; 635; -2 <3198>: SFP; 315%; 77,900; 0.15; 2163; -5 <8118>: King; 254%; 6,100; 62.03; 755; 0 <9428>: Crops; 20
No Data